FHIM 2026

November 4-5, 2026

Shanghai, China

FHIM (Future Healthcare Investment Market) is an international healthcare investment and business cooperation platform created by IPEM (International Private Equity Market) and Healthcare Business International (HBI). Taking place in Shanghai on 4–5 November 2026, FHIM will connect senior decision-makers from China, wider Asia and Europe across pharmaceuticals, biotechnology, healthcare services, medical technology and private capital. The event is designed as a working marketplace for cross-border partnerships—not simply a conference—bringing together companies, investors, hospitals, healthcare groups, research and clinical institutions, procurement organisations, industry associations and professional advisers around concrete business needs. Its focus includes licensing and business development, investment and M&A, clinical collaboration, technology adoption, international market entry, procurement, distribution, joint R&D and global commercialisation.

WHO FHIM IS FOR

FHIM is particularly relevant to pharmaceutical, biotechnology, healthcare and MedTech companies in Asia and Europe that are seeking practical routes to international growth. The event is designed for senior executives and decision-makers, including founders, chairpersons, CEOs and C-level executives; business development and licensing leaders; R&D and clinical executives; international business, regulatory and market-access teams; hospital and healthcare-group executives; procurement and innovation leaders; and partners from private equity, venture capital, corporate investment and institutional capital.

For Asian companies, FHIM provides direct access to European pharmaceutical and biotechnology partners, hospital groups, healthcare buyers, investors, market-entry expertise and international commercial networks. For European companies and institutions, it offers a structured entry point into China and the wider Asian healthcare ecosystem, including innovation pipelines, clinical and research capabilities, manufacturing and supply-chain capacity, commercial partners and a large, fast-evolving healthcare market.